QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS

• 收藏
• 分享

专利权人:

Merck Sharp & Dohme Corp.

发明人:

PALANI, Anandan,ASLANIAN, Robert, G.,BOYCE, Christopher, W.,MAZZOLA, Robert, D.,Jr.,MCKITTRICK, Brian, A.,MCCORMICK, Kevin, D.,QIN, Jun,TANG, Haiqun,XIAO, Dong,YU, Younong,CALDWELL, John, P.,KELLEY, Elizabeth, Helen,ZHANG, Hongjun,SILIPHAIVANH, Phieng,MACCOSS, Rachel, N.,METHOT, Joey, L.,GAUUAN, Jolicia Polivina,JIANG, Qin,LEYHANE, Andrew, J.,BIJU, Purakkattle Johny,DONG, Li,HUANG, Xianhai,SHAO, Ning,ZHOU, Wei,DHONDI, Pawan, K.,RAO, Ashwin, U.

申请号：

EP20110833150

公开号：

EP2627178(B1)

申请日:

2011.10.06

申请国别(地区):

欧洲专利局

年份:

2018

代理人:

摘要：

This application provides for compounds of the formula Formula I or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTH2 receptor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/